Literature DB >> 4777255

Renal effects of bumetanide, a new saluretic agent.

S G Karlander, R Henning, O Lundvall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4777255     DOI: 10.1007/bf00644735

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  [SITE AND MECHANISM OF ACTION OF FUROSEMIDE IN THE DISTAL NEPHRON IN HUMANS].

Authors:  E BUCHBORN; S ANASTASAKIS
Journal:  Klin Wochenschr       Date:  1964-11-15

2.  Evaluation in man of bumetanide, a new diuretic agent.

Authors:  R Henning; O Lundvall
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

3.  Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulfamylbenzoic acid (Bumetanide), a new potent diuretic.

Authors:  E H Ostergaard; M P Magnussen; C K Nielsen; E Eilertsen; H H Frey
Journal:  Arzneimittelforschung       Date:  1972-01

4.  The effect of furosemide, a new diuretic agent, on renal concentrating and diluting mechanisms.

Authors:  P A Morrin
Journal:  Can J Physiol Pharmacol       Date:  1966-01       Impact factor: 2.273

5.  Bumetanide: potent new "loop" diuretic.

Authors:  M J Asbury; P B Gatenby; S O'Sullivan; E Bourke
Journal:  Br Med J       Date:  1972-01-22

6.  An experimental study on serotonin (5-hydroxytryptamine;5HT) on man with special reference to renal function.

Authors:  G BOJS
Journal:  Scand J Clin Lab Invest       Date:  1961       Impact factor: 1.713

7.  Aminobenzoic acid diuretics. 2. 4-Substituted-3-amino-5-sulfamylbenzoic acid derivatives.

Authors:  P W Feit
Journal:  J Med Chem       Date:  1971-05       Impact factor: 7.446

  7 in total
  7 in total

1.  Evaluation in man of bumetanide, a new diuretic agent.

Authors:  R Henning; O Lundvall
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

2.  Application of effect-compartment model to bumetanide-indomethacin interaction in dogs.

Authors:  D E Smith; H S Lau; J L Fox
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

3.  Bumetanide: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Development of acute tolerance to bumetanide: constant-rate infusion studies.

Authors:  J A Cook; D E Smith
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

5.  Determinants of bumetanide response in the dog: effect of probenecid.

Authors:  D E Smith; H S Lau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

6.  Diuretic action of bumetanide in advanced chronic renal insufficiency.

Authors:  K J Berg; A Tromsdal; T E Wideroe
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

Review 7.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.